Frontlight ResearchEarly access
Trial site
Velocity Clinical Res-Dallas
- 6running trials
- 16closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes16 trials
- Obesity7 trials
- Diabetic eye disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Peripheral artery disease1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 318 trials
- Phase 24 trials
- Status
- Completed16 trials
- Active, not recruiting5 trials
- Recruiting1 trial
- Lead sponsor
- Novo Nordisk A/S22 trials
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
Active, not recruiting
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes
Site data: ClinicalTrials.govUpdated 17 Nov 2026